Home › Calculator › EW Dividend Calculator 2026
EW Dividend Calculator 2026
No dividendHealthcareEdwards Lifesciences Corporation · NYSE
Price: $89.07 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
Calculator settings
EW is not a dividend-focused stock
EW pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
EW Dividend Yield
Edwards Lifesciences Corporation (EW) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When EW pays your bills
Year your monthly dividend income covers each expense (based on current settings)
About Edwards Lifesciences Corporation (EW) — Dividend Analysis 2026
Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions. Their structural heart disease portfolio encompasses transcatheter heart valve replacement systems designed for minimally invasive procedures, as well as transcatheter repair and replacement options specifically targeting mitral and tricuspid valve pathologies, exemplified by their PASCAL and Cardioband systems. Additionally, they provide advanced surgical structural heart solutions, including the INSPIRIS aortic surgical valve, the KONECT RESILIA pre-assembled aortic tissue valved conduit for complex valve, root, and ascending aorta replacements, and the HARPOON Beating Heart Mitral Valve Repair System for patients suffering from degenerative mitral regurgitation. In the realm of critical care, Edwards supplies advanced hemodynamic monitoring systems that assess patients' cardiac function and fluid status in both surgical and intensive care environments. This offering also features the Acumen Hypotension Prediction Index software, which provides early alerts to clinicians regarding potential dangerously low blood pressure. The company distributes its products to healthcare providers through a combination of its proprietary sales force and independent distributor networks. Founded in 1958, Edwards Lifesciences Corporation maintains its headquarters in Irvine, California.
EW Dividend & DRIP — Frequently Asked Questions
Does EW pay a dividend?
No. Edwards Lifesciences Corporation (EW) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
How can I get dividend income instead of EW?
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
Does EW have a DRIP (dividend reinvestment plan)?
A DRIP reinvests dividends into new shares. EW has no regular dividend in our data, so there is nothing to reinvest.
Stocks similar to EW
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full EW DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open EW position with:
🌍 EW Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold EW.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 EW Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 EW Dividend Payment Schedule
EW pays quarterly — 4 times per year. Ex-div: —.
📊 EW vs Healthcare Benchmarks
How EW compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for EW sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ EW Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| M-Exempt | 2026-10-08 | 619 | $72.68 | $45.0K | ||
| Sale | 2026-10-08 | 619 | $85.65 | $53.0K | ||
| M-Exempt | 2026-10-08 | 619 | $72.68 | $45.0K | ||
| F-InKind | 2026-09-11 | 355 | $86.77 | $30.8K | ||
| F-InKind | 2026-09-14 | 568 | $84.37 | $47.9K | ||
| F-InKind | 2026-09-13 | 253 | $84.37 | $21.3K | ||
| F-InKind | 2026-09-11 | 398 | $86.77 | $34.5K | ||
| M-Exempt | 2026-09-11 | 619 | $72.68 | $45.0K | ||
| Sale | 2026-09-11 | 619 | $87.51 | $54.2K | ||
| M-Exempt | 2026-09-11 | 619 | $72.68 | $45.0K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Peer Group
Similar companies in the same sectorCompare EW with peers: EW vs A · EW vs ALC · EW vs ARGX
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where EW earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the EW dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Edwards Lifesciences Corporation (EW) is currently trading at $89.07, 7% below its 52-week high. It does not currently pay a regular dividend.
Edwards Lifesciences Offers No Dividend Yield, Focusing Capital on Innovation
AI SummaryEdwards Lifesciences Corporation operates as a major player in the Healthcare sector with a market capitalization of $50.2 billion and a share price of $87.23. However, the company does not currently pay an annual dividend, resulting in a dividend yield of 0.00% and a 5-year dividend CAGR of 0%. Consequently, metrics regarding dividend safety and payout ratios are not applicable, as management chooses to retain all earnings rather than distribute income to shareholders. Operating at a high P/E ratio of 47.7, the firm directs its financial resources toward research, development, and market expansion within structural heart disease solutions. Because the dividend yield is zero, sustainability questions center entirely on capital allocation strategies rather than payout coverage. Income-seek
- Complete absence of dividend income for investors seeking cash flow
- High valuation multiples leaving little room for operational missteps
Generated by AI using live market data. For educational purposes only — not financial advice.
Latest EW News
LiveProjected your EW DRIP returns?
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.